Latest Announcements

Kellton Tech Solutions Ltd has scheduled a board meeting on 23/09/2026 to consider a proposal for raising funds through the issuance of equity shares and/or other eligible securities.

Swastika Investmart Ltd has received in-principle approval from BSE for the issuance of 90,50,000 warrants convertible into equivalent equity shares on a preferential basis to promoters and non-promoters.

Cohance Lifesciences Ltd has invested USD 10 million in Compulsorily Convertible Preferred Stock of NJ Bio Inc., a subsidiary, to support its growth initiatives.

Technojet Consultants Ltd has announced the approval of a preferential issue of up to 5,00,000 equity shares at Rs. 48 per share to non-promoter investors, subject to shareholder approval. The company also plans to increase its authorized share capital and has scheduled an EGM on October 30, 2026.

Bank of Maharashtra has concluded the issuance of Senior Unsecured Fixed Rate Notes amounting to USD 500 Million under its USD 500 Million Medium Term Note Programme.

Kalind Ltd has withdrawn its proposal for issuing up to 27.48 crore warrants and instead approved a fresh proposal for issuing up to 8.60 crore equity shares on a preferential basis to three non-promoter entities at ₹11.50 per share, aggregating to ₹98.99 crore.

Kalind Ltd has withdrawn its proposal for issuing up to 27.48 crore warrants, convertible into equity shares, and approved a fresh proposal for issuing up to 8.60 crore equity shares on a preferential basis to three non-promoter entities at ₹11.50 per share.

Abans Financial Services Ltd has revised the allotment of equity shares under its ESOP Scheme 2023 due to an operational issue, increasing the total number of shares to 3,75,365. The revised issued, subscribed, and paid-up equity share capital of the company stands at Rs. 10,24,30,248, consisting of 5,12,15,124 equity shares.

Purple Finance Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 22/09/2026 to consider and approve fund raising by way of issuance of securities through rights issue, qualified institutions placement, or any other method.

Hemo Organic Ltd has informed about the outcome of its Board Meeting held on 17th September, 2026, where the Board considered and took note of the receipt of the 2nd tranche of consideration of convertible warrants amounting to Rs. 2,76,25,000/- from non-promoter category allottees. Upon receipt of the remaining consideration and valid exercise and conversion of the outstanding warrants, the paid-up Equity Share Capital of the Company would increase.

Quint Digital Ltd has received listing and trading approval from BSE Limited for partly paid-up compulsorily convertible preference shares and partly paid-up warrants, effective from September 18, 2026.

Punjab National Bank has established a Euro Medium Term Note Programme of USD 1.50 Billion, with the offering circular available on the India International Exchange (IFSC) Limited website.

Neogen Chemicals Ltd has announced the outcome of its Fund-Raising Committee meeting, approving the closure of its Qualified Institutions Placement (QIP) issue, issue price, placement document, and allocation note. The QIP was opened on September 10, 2026, and 26,60,753 equity shares were subscribed for at ₹2,255 per share.

Neogen Chemicals Ltd has completed its Qualified Institutional Placement (QIP) with an issue price of ₹2,255 per equity share, allotting 26,60,753 shares to eligible QIBs.

Anupam Rasayan India Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 19/09/2026 to consider and approve the fund raising of up to INR 160,00,00,000/- by way of issuance of Secured Rated Unlisted Redeemable Non-Convertible Debentures on Private Placement basis.

Suryoday Small Finance Bank Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 21/09/2026 to consider and approve raising of funds by issue of Non-Convertible Debentures on Private Placement basis.

Venus Pipes & Tubes Ltd has announced an Extraordinary General Meeting (EGM) to consider the issuance of equity shares on a preferential basis to various proposed allottees.

Fredun Pharmaceuticals Ltd has allotted 271,200 equity shares upon conversion of warrants to non-promoter investors, with the allotment made in dematerialized form and the shares ranking pari passu with existing equity shares.

Fredun Pharmaceuticals Ltd has allotted 2,71,200 equity shares to non-promoters upon conversion of warrants into equity shares, as per the approval of shareholders in their Extra-Ordinary General Meeting held on October 22, 2025.

Gconnect Logitech and Supply Chain Ltd has scheduled a board meeting on 19/09/2026 to consider a proposal for raising funds through a rights issue of equity shares to eligible shareholders, subject to regulatory approvals.